Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies

Ann Endocrinol (Paris). 2020 Jun;81(2-3):124-125. doi: 10.1016/j.ando.2020.04.002. Epub 2020 Apr 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenoma / complications
  • Adenoma / genetics
  • Adenoma / pathology
  • Aged
  • Cyclin-Dependent Kinase Inhibitor p27 / genetics*
  • Female
  • Humans
  • Hyperprolactinemia / complications
  • Hyperprolactinemia / genetics
  • Hyperprolactinemia / pathology
  • Immune System Diseases / etiology
  • Immune System Diseases / genetics*
  • Multiple Endocrine Neoplasia / complications*
  • Multiple Endocrine Neoplasia / diagnosis
  • Multiple Endocrine Neoplasia / genetics*
  • Multiple Endocrine Neoplasia / pathology
  • Parathyroid Neoplasms / complications
  • Parathyroid Neoplasms / genetics
  • Parathyroid Neoplasms / pathology
  • Phenotype
  • Pituitary Neoplasms / complications
  • Pituitary Neoplasms / genetics
  • Pituitary Neoplasms / pathology

Substances

  • CDKN1B protein, human
  • Cyclin-Dependent Kinase Inhibitor p27

Supplementary concepts

  • Multiple Endocrine Neoplasia, Type IV